Transparency
Market Research’s report on the global ophthalmic drugs market
offers a detailed segmentation of this market. The report is titled
“Ophthalmic Drugs Market - Global Industry Analysis, Size, Share,
Growth, Trends and Forecast, 2013 - 2018”. The TMR report states
that the global ophthalmic drugs market will expand at a CAGR of 5.2%
during the forecast period of 2013 to 2018. By 2018, the market is
expected to be worth US$21.6 billion; in 2012, this market was valued
at US$16 billion.Globally, the demand for ophthalmic drugs in the
form of ointments and drops is rising due to the increasing
prevalence of eye disorders. The top reasons for blindness and other
vision defects in the U.S. are age-related conditions such as
cataract, glaucoma, diabetic retinopathy, and age-related macular
degeneration. Thus, the accelerating geriatric population will also
drive the demand for ophthalmic drugs worldwide.
Browse
the full Ophthalmic Drugs Market Report at
http://www.transparencymarketresearch.com/ophthalmic-drugs-market.html
Apart
from these primary factors, the increasing number of government
initiatives to improve healthcare infrastructure in emerging nations
will also drive the global ophthalmic drugs market. Furthermore, the
technological advancements in drug delivery techniques, such as
noninvasive techniques, and the rising prevalence of
lifestyle-related medical conditions will also drive the global
ophthalmic drugs market.The global ophthalmic drugs market will also
benefit from the elevated focus on combination therapy. Combination
therapy offers several advantages over the conventional approach,
such as improved patient compliance, enhanced efficacy, and reduced
frequency of eye drop application.
By
treatment drugs, the global ophthalmic drugs market is divided into
anti-glaucoma drugs, anti-inflammatory/infective/allergy drugs,
retinal drugs, and dry eye drugs. Glaucoma dominates the global
ophthalmic drugs market and is projected to demonstrate a CAGR of
4.2% during the forecasting horizon. By drug type, the global
ophthalmic drugs market is segmented into OTC (over-the-counter)
drugs and prescription drugs.By geography, the global ophthalmic
drugs market is divided into North America, Asia Pacific, Europe, and
Rest of the World. Currently, North America is the largest market for
ophthalmic drugs. On the other hand, Asia Pacific is the fastest
growing regional market. Country-wise, China and India are two of the
fastest growing markets in the global ophthalmic drugs market.
Developed
countries of North America and Europe are expected to show good
growth in demand from the global ophthalmic drugs market, due to the
elevated efforts to prevent blindness among the geriatric population
in these countries. The rising number of mergers and acquisitions in
the market are expected to contribute to the growth of the global
ophthalmic drugs market. Recently, Allergan added an eye specialist
firm called Oculeve to its portfolio. In 2012, Novartis (Alcon) led
the global ophthalmic drugs market with an impressive market share of
24%. Other key players operating in the global ophthalmic drugs
market include Pfizer, Allergan, Merck and Roche, and Santen.Even
though the global ophthalmic drugs market will demonstrate positive
growth in the foreseeable future, it will be constrained to an extent
by the drying pipeline for ophthalmic drugs and the lack of health
insurance in emerging countries.
Browse
the full Press Release:
http://www.transparencymarketresearch.com/pressrelease/ophthalmic-drugs-market.htm
Ophthalmic
Drugs Market, By Treatment Drugs
Dry
Eye Drugs
Retinal
Drugs
Anti-inflammatory/allergy/infective
Drugs
Anti-glaucoma
Drugs
Ophthalmic
Drugs Market, By Types
Prescription
Drugs
OTC
Drugs
Ophthalmic
Drugs Market, by Geography
North
America
U.S.
Europe
Germany
U.K.
France
Asia
Pacific
Japan
China
India
Rest
of the World (RoW)
Request
a Brochure of this Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1769
About
Us
Transparency
Market Research (TMR) is a global market intelligence company
providing business information reports and services. The company’s
exclusive blend of quantitative forecasting and trend analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants
use proprietary data sources and various tools and techniques to
gather and analyze information.
TMR’s
data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and
information. With extensive research and analysis capabilities,
Transparency Market Research employs rigorous primary and secondary
research techniques to develop distinctive data sets and research
material for business reports.
Contact
Mr.
Nachiket
State
Tower,
90
State Street,
Suite
700,
Albany
NY - 12207
United
States
Tel:
+1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
http://www.transparencymarketresearch.com
No comments:
Post a Comment